http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/ Y! Health News Search RSS Feed, updated continuously. en-us Fri, 25 Jul 2008 07:52:26 PDT Copyright (c) 2008 Yahoo! Inc. All rights reserved. 5 142 18 http://health.yahoo.com/ http://us.i1.yimg.com/us.yimg.com/i/us/he/b/he_144.gif http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/targeteddrugboostssurvivalamonglivercancerpatients.htmlyahoo/health/news/healthday/targeteddrugboostssurvivalamonglivercancerpatientsWed, 23 Jul 2008 20:46:44 PDTHealthDay - WEDNESDAY, July 23 (HealthDay News) -- The drug Nexavar can prolong the lives of people with liver cancer by an average of three months, new research shows.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/healthhighlightsjuly232008.htmlyahoo/health/news/healthday/healthhighlightsjuly232008Wed, 23 Jul 2008 11:02:49 PDTHealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/healthhighlightsjuly222008.htmlyahoo/health/news/healthday/healthhighlightsjuly222008Tue, 22 Jul 2008 20:47:34 PDTHealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/geneprofilesmighthelpguidelungcancercare.htmlyahoo/health/news/healthday/geneprofilesmighthelpguidelungcancercareMon, 21 Jul 2008 20:47:28 PDTHealthDay - SUNDAY, July 20 (HealthDay News) -- A sweeping genetic analysis suggests that the activity of certain genes might someday allow doctors to predict which lung cancer patients need more aggressive therapies and which do not.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/lungcancertrialtargetsasbestosrelateddisease.htmlyahoo/health/news/healthday/lungcancertrialtargetsasbestosrelateddiseaseMon, 21 Jul 2008 20:47:22 PDTHealthDay - MONDAY, July 21 (HealthDay News) -- Patients are being recruited for a clinical trial of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that's almost always caused by exposure to asbestos.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/cancer_lung_dc.htmlyahoo/health/news/reuters/cancer_lung_dcSun, 20 Jul 2008 10:20:37 PDTReuters - U.S. and Canadian researchers have taken steps toward developing a gene test to determine whether a patient's lung cancer is especially aggressive, or whether radical treatment can be avoided.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/drugcomboimprovesremissionofrheumatoidarthritis.htmlyahoo/health/news/healthday/drugcomboimprovesremissionofrheumatoidarthritisWed, 16 Jul 2008 20:46:28 PDTHealthDay - WEDNESDAY, July 16 (HealthDay News) -- Patients with moderate-to-severe rheumatoid arthritis benefited from combining the drugs methotrexate and Enbrel (etanercept), new research found.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/casepointstolinkbetweencrohnstreatmentcancer.htmlyahoo/health/news/healthday/casepointstolinkbetweencrohnstreatmentcancerWed, 16 Jul 2008 20:46:23 PDTHealthDay - WEDNESDAY, July 16 (HealthDay News) -- An unusual case involving a sudden remission of lung cancer highlights the carcinogenic potential of certain drugs used to treat Crohn's disease, experts say.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/braincancervaccinesimmuneresponsekeytooutcomes.htmlyahoo/health/news/healthday/braincancervaccinesimmuneresponsekeytooutcomesTue, 15 Jul 2008 20:46:45 PDTHealthDay - TUESDAY, July 15 (HealthDay News) -- An in-trial dendritic cell vaccine that fights malignant brain tumors called glioblastoma multiforme (GBM) may help boost a patient's immunity response and improve the outcome, a new report says.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/genentech_avastin_dc.htmlyahoo/health/news/reuters/genentech_avastin_dcMon, 14 Jul 2008 13:15:55 PDTReuters - Genentech Inc has warned doctors about a type of anemia seen in patients treated with the company's blockbuster cancer drug Avastin in combination with Pfizer Inc's Sutent in a clinical trial, U.S. regulators said in a notice issued on Monday.